Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of biologically active compounds targeting central nervous system disorders and metabolic diseases. Its structure supports the formation of stable, selective drug candidates due to the stereochemical integrity and the electron-withdrawing effect of the difluoroethyl group. Commonly employed in medicinal chemistry for constructing peptidomimetics and enzyme inhibitors, especially in programs focused on diabetes and neurodegenerative conditions.